A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo

Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291)
11/1994
11/22/1994	US5367080 Pyridine derivatives
11/22/1994	US5367056 Endothelial cell-leukocyte adhesion molecules (ELAMs) and molecules involved in leukocyte adhesion (MILAs)
11/22/1994	US5366721 Method for detection of long-lived radioisotopes in small biochemical samples
11/17/1994	EP0624097A1 Targeting radioactive immunoreagents
11/17/1994	EP0624096A1 Taxol as a radiation sensitizer
11/17/1994	EP0109441B1 Human-human hybridomas for neoplasms
11/16/1994	CN1094965A Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of b cell lymphoma
11/15/1994	US5364614 Cascade polymer bound chelating compounds, their chelates and conjugates, processes for their production, and pharmaceutical agents containing them
11/15/1994	US5364613 Polychelants containing macrocyclic chelant moieties
11/15/1994	US5364612 Detection of cardiovascular lesions
11/15/1994	US5363846 Method for the diagnosis and treatment of inflammation
11/10/1994	WO1994025581A1 Modified recombinant tissue plasminogen activator
11/10/1994	WO1994025488A1 Method for preparing a metal-radionuclide-labelled protein
11/10/1994	WO1994024959A1 Method of detecting compounds utilizing chemically modified lambdoid bacteriophage
11/10/1994	CA2159716A1 Method of detecting compounds utilizing chemically modified lambdoid bacteriophage
11/10/1994	CA2141739A1 Method for preparing a metal-radionuclide-labelled protein
11/09/1994	EP0623134A1 Metal complexes of water soluble texaphyrins
11/09/1994	EP0623028A1 Nitrogen-sulfur ligands as opiate receptor mimics
11/09/1994	EP0623020A1 Pyropheophorbides and their use in photodynamic therapy
11/09/1994	EP0436664B1 Cleavable linkers for the reduction of non-target organ retention of immunoconjugates
11/08/1994	US5362852 Modified peptide derivatives conjugated at 2-hydroxyethylamine moieties
11/08/1994	US5362476 Contrast agents for magnetic resonance imaging
11/08/1994	US5362474 Method for detecting and locating inflammatory or tumor foci in a patient and diagnostic kit therefor
11/08/1994	US5362473 Radiolabelled particulate composition
11/06/1994	CA2095569A1 Composition and method
11/02/1994	EP0621786A1 Induced tolerance to xenografts
10/1994
10/27/1994	WO1994024156A1 Thrombin inhibitors, the preparation thereof and the use thereof for therapeutical, prophylactic and diagnostic applications
10/27/1994	WO1994024145A1 Derivatives of triterpenoid acids and uses thereof
10/27/1994	WO1994023759A1 Improved detection and therapy of lesions with biotin/avidin polymer conjugates
10/27/1994	WO1994023758A1 Radiolabeled compounds for thrombus imaging
10/27/1994	WO1994023757A1 Use of cyclopentadienylcarbonyl transition metal carboxylic acids and their derivatives for labelling proteins
10/27/1994	WO1994023756A1 Neural thread protein gene expression and detection of alzheimer's disease
10/27/1994	WO1994023747A1 Drug containing antibodies for treatment of t cell specific immune reactions and t cells leukemias
10/27/1994	WO1994023649A1 Treated calcium/oxyanion-containing particles for medical diagnostic imaging
10/27/1994	CA2161109A1 Improved detection and therapy of lesions with biotin/avidin polymer conjugates
10/27/1994	CA2161097A1 Neural thread protein gene expression and detection of alzheimer's disease
10/27/1994	CA2160979A1 Use of cyclopentadienylcarbonyl transition metal carboxylic acids and their derivatives for labeling proteins
10/27/1994	CA2160537A1 Thrombin inhibitors, the preparation thereof and the use thereof for therapeutical prophylactic and diagnostic applications
10/27/1994	CA2160370A1 Derivatives of triterpenoid acids and uses thereof
10/27/1994	CA2160120A1 Radiolabeled compounds for thrombus imaging
10/27/1994	CA2159799A1 Treated calcium/oxyanion-containing particles for medical diagnostic imaging
10/25/1994	US5358712 Radiopharmaceutical agents for the detection of Alzheimer's disease
10/19/1994	EP0644775A4 Cocaine receptor binding ligands.
10/19/1994	EP0449825B1 Improved emulsions of highly fluorinated organic compounds
10/18/1994	US5357042 Synthetic peptides capable of eliciting fibrin-specific monoclonal antibodies lacking fibrinogen-cross-reactivity
10/17/1994	EP0630264A4 Ligands for improving metal chelate formation kinetics.
10/13/1994	WO1994022816A1 Metal chelating compounds
10/13/1994	WO1994022497A1 Chelating agents of the type xn1s1o1 for radioactive isotopes, metal complexes thereof, and their use in diagnosis and therapy
10/13/1994	WO1994022496A1 Radiopharmaceutical formulations having non-stannous reductants
10/13/1994	WO1994022495A1 Dopamine d-3 and serotonin (5-ht1a) receptor ligands and imaging agents
10/13/1994	WO1994022494A1 RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS
10/13/1994	WO1994022493A1 Chelators of type xn1s1x' for radioactive isotopes, their metal complexes and their diagnostic and therapeutical uses
10/13/1994	WO1994022492A1 Type s3n2 chelators for radioactive isotopes, their metal complexes and their diagnostic and therapeutical use
10/13/1994	WO1994022491A1 Bifunctional chelators and their use in radiopharmaceuticals
10/13/1994	WO1994022490A1 Conjugates of proteins and bifunctional ligands
10/13/1994	CA2159445A1 Radiolabeled platelet gpiib/iiia receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
10/13/1994	CA2158249A1 Radiopharmaceutical formulations having non-stannous reductants
10/13/1994	CA2156641A1 Type s3n2 chelators for radioactive isotopes, their metal complexes and their diagnostic and therapeutical use
10/13/1994	CA2156620A1 Chelating agents of the type xn1s1o for radioactive isotopes, metal complexes thereof, and their use in diagnosis and therapy
10/13/1994	CA2156619A1 Chelators agents of the type xn1s1x' for radioactive isotopes, their metal complexes and their diagnostic and therapeutical uses
10/13/1994	CA2156618A1 Bifunctional chelators and their use in radiopharmaceuticals
10/13/1994	CA2136970A1 Metal chelating compounds
10/12/1994	EP0618969A1 Composite antibodies of human subgroup iv light chain capable of binding to tag-72
10/12/1994	EP0618910A1 Synthesis of polyazamacrocycles with more than one type of side-chain chelating groups
10/12/1994	EP0618816A1 Further improvements relating to the radiolabelling of proteins
10/12/1994	EP0425566B1 New photosensitizing agents
10/12/1994	EP0408701B1 Macrocyclic aminophosphonic acid complexes, their preparation, formulations and use
10/11/1994	US5355394 Method for producing actinium-225 and bismuth-213
10/11/1994	US5354554 Crosslinked antibodies and processes for their preparation
10/05/1994	EP0618191A1 Metal chelating compounds
10/05/1994	EP0461245A4 Radiolabeled proteins for diagnostic or therapeutic use
10/05/1994	CN1093084A Rhenium and technetium complexes containing a hypoxia-localizing moiety
10/04/1994	US5352431 Polynuclear; including bifunctional ligand coordinated to radiopaque metal ion(s); administering for medical diagnosis
09/1994
09/29/1994	WO1994021673A1 Alpha-ketoamide derivatives as inhibitors of thrombosis
09/29/1994	WO1994021304A1 Novel heterocycle based nitrogen-sulfur ligands useful in radiographic imaging agents
09/29/1994	WO1994021294A1 Method of treating tumors with antibodies
09/29/1994	WO1994021293A1 Method of treatment of tumors with an antibody binding to tenascin
09/29/1994	CA2158989A1 Alpha-ketoamide derivatives as inhibitors of thrombosis
09/28/1994	EP0616532A1 Use of peripheral-type benzodiazepine sites for treatment of cns trauma or disease
09/28/1994	CN1025983C Macrocyclic aminophosphonic acid complexes, their preparation formulations and use
09/27/1994	US5350840 Diagnosis
09/27/1994	US5350837 Complexes with 99m Tc suitable for radiolabelling monoclonal antibodies or other macro molecules
09/27/1994	US5350571 Contrast agents for images in medical diagnosis
09/21/1994	EP0420934B1 Bifunctional coupling agents and radionuclide labeled compositions prepared therefrom
09/21/1994	CN1092424A Wavelength-specific photosensitive porphacyanine and expanded porphyrin-like compounds and methods for preparation and use thereof
09/20/1994	US5348954 Heterocyclic chelating agents
09/15/1994	WO1994020839A1 Process for stripping radon-220 from radioactive isotope mixture
09/15/1994	WO1994020523A1 Tumor targeting with l-enantiomeric oligonucleotide conjugates of immunoreagents and of chelated radionuclides
09/15/1994	WO1994020148A1 Imidazole based nitrogen-sulfur ligands useful in radiographic imaging agents
09/15/1994	CA2157902A1 Tumour targeting with l-enantiomeric oligonucleotide conjugates of immunoreagents and of chelated radionuclides
09/14/1994	EP0614667A1 Agent for preventing adhesion of thallium 201 to container
09/14/1994	EP0614379A1 TECHNETIUM-99m LABELED PEPTIDES FOR IMAGING
09/14/1994	EP0614378A1 TECHNETIUM-99 m COMPLEXES WITH N-SUBSTITUTED 3-HYDROXY-4-PYRIDINONES
09/14/1994	EP0614377A1 Method for diagnosing and treating cancer
09/14/1994	EP0614374A1 MURINE MONOCLONAL ANTIBODY (5c8) RECOGNIZES A HUMAN GLYCOPROTEIN ON THE SURFACE OF T-LYMPHOCYTES
09/13/1994	US5347030 Radioiodinated phospholipid ether analogues and methods of using same
09/13/1994	US5346696 Recombinent Interferon
09/13/1994	US5346687 Partial reduction of disulfide bonds with stannous compound
09/13/1994	US5346686 Labelled interleukin-8 and medical uses thereof
09/07/1994	EP0613379A1 Therapeutic compounds

1 ... 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 ... 243